AstraZeneca PLC ADR (AZN): Price and Financial Metrics

AZN POWR Grades

• Sentiment is the dimension where AZN ranks best; there it ranks ahead of 96.1% of US stocks.
• The strongest trend for AZN is in Value, which has been heading up over the past 178 days.
• AZN's current lowest rank is in the Momentum metric (where it is better than 12.39% of US stocks).

AZN Stock Summary

• With a market capitalization of $204,707,520,000, ASTRAZENECA PLC has a greater market value than 99.28% of US stocks.
• AZN's current price/earnings ratio is 100.4, which is higher than 95.35% of US stocks with positive earnings.
• In terms of volatility of its share price, AZN is more volatile than merely 12.89% of stocks we're observing.
• If you're looking for stocks that are quantitatively similar to ASTRAZENECA PLC, a group of peers worth examining would be NVS, BABA, BMY, DHR, and ABT.
• AZN's SEC filings can be seen here. And to visit ASTRAZENECA PLC's official web site, go to www.astrazeneca.com.

AZN Valuation Summary

• In comparison to the median Healthcare stock, AZN's price/sales ratio is 4.26% lower, now standing at 4.5.
• Over the past 242 months, AZN's EV/EBIT ratio has gone up 80.3.

Below are key valuation metrics over time for AZN.

AZN Growth Metrics

Its 3 year revenue growth rate is now at 85.19%.
• Its year over year cash and equivalents growth rate is now at -24.54%.
• Its year over year net income to common stockholders growth rate is now at -126.73%.

Over the past 55 months, AZN's revenue has gone up $22,916,000,000.

The table below shows AZN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	45,154	8,828	2,039
2022-06-30	44,038	7,617	-1,253
2022-03-31	41,487	7,261	-1,063
2021-12-31	37,417	5,963	112
2021-12-31	37,417	5,963	112
2021-09-30	32,816	6,343	1,471

AZN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• AZN has a Quality Grade of B, ranking ahead of 78.56% of graded US stocks.
• AZN's asset turnover comes in at 0.438 -- ranking 104th of 681 Pharmaceutical Products stocks.
• CLVS, HSKA, and FLXN are the stocks whose asset turnover ratios are most correlated with AZN.

The table below shows AZN's key quality metrics over time.